Researchers at Ayass Bioscience have discovered and developed AYA22A aptamers, molecular compounds that target and bind to ...
The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback